This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignee: Stemcell Technologies Canada Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Finola Moore: Innovator in Immunology
Introduction
Finola Moore is a distinguished inventor based in Watertown, MA (US). He has made significant contributions to the field of immunology through his innovative research and patented inventions. His work focuses on methods to induce tolerance and suppress immune responses, which has important implications for medical treatments.
Latest Patents
Finola Moore holds a patent for "Intracellular delivery of biomolecules to induce tolerance." This invention provides methods for inducing tolerance and/or suppressing an immune response to an antigen by passing a cell suspension containing an anucleate cell through a constriction. The constriction deforms the cell, causing a perturbation that allows an antigen and/or tolerogenic factor to enter the cell. In some embodiments, the anucleate cell is delivered to an individual, and the antigen is processed in a tolerogenic environment to induce tolerance and/or suppress an immune response.
Career Highlights
Finola Moore is currently associated with Stemcell Technologies Canada Inc., where he continues to advance his research in immunology. His work has garnered attention for its potential to improve therapeutic strategies in treating various immune-related conditions.
Collaborations
Finola has collaborated with notable colleagues, including Jonathan B. Gilbert and Bu Wang, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Finola Moore's contributions to immunology through his patented inventions highlight his role as a leading inventor in the field. His innovative methods for inducing tolerance have the potential to transform therapeutic approaches in medicine.